Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Lu, Ph.D.

Co-Author

This page shows the publications co-authored by Christine Lu and Dennis Ross-Degnan.
Connection Strength

3.259
  1. Wharam JF, Busch AB, Madden J, Zhang F, Callahan M, LeCates RF, Foxworth P, Soumerai S, Ross-Degnan D, Lu CY. Effect of high-deductible insurance on health care use in bipolar disorder. Am J Manag Care. 2020 Jun; 26(6):248-255.
    View in: PubMed
    Score: 0.247
  2. Lu CY, Ross-Degnan D, Zhang F, LeCates R, Lupton C, Sherman M, Wagner A. Cost burden of hepatitis C virus treatment in commercially insured patients. Am J Manag Care. 2019 12 01; 25(12):e379-e387.
    View in: PubMed
    Score: 0.238
  3. Lu CY, Zhang F, Wagner AK, Nekhlyudov L, Earle CC, Callahan M, LeCates R, Xu X, Ross-Degnan D, Wharam JF. Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer. Breast Cancer Res Treat. 2018 Aug; 171(1):235-242.
    View in: PubMed
    Score: 0.214
  4. Wharam JF, Zhang F, Lu CY, Wagner AK, Nekhlyudov L, Earle CC, Soumerai SB, Ross-Degnan D. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. J Clin Oncol. 2018 04 10; 36(11):1121-1127.
    View in: PubMed
    Score: 0.211
  5. Wharam JF, Zhang F, Eggleston EM, Lu CY, Soumerai SB, Ross-Degnan D. Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study. Diabetes Care. 2018 05; 41(5):940-948.
    View in: PubMed
    Score: 0.210
  6. Wharam JF, Zhang F, Eggleston EM, Lu CY, Soumerai S, Ross-Degnan D. Diabetes Outpatient Care and Acute Complications Before and After High-Deductible Insurance Enrollment: A Natural Experiment for Translation in Diabetes (NEXT-D) Study. JAMA Intern Med. 2017 03 01; 177(3):358-368.
    View in: PubMed
    Score: 0.197
  7. Hsu JC, Cheng CL, Ross-Degnan D, Wagner AK, Zhang F, Kao Yang YH, Liu LL, Tai HY, Chen KH, Yang PW, Lu CY. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan. Pharmacoepidemiol Drug Saf. 2015 Oct; 24(10):1026-35.
    View in: PubMed
    Score: 0.177
  8. Hsu JC, Ross-Degnan D, Wagner AK, Zhang F, Lu CY. How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid? Clin Ther. 2015 Jul 01; 37(7):1420-1432.e1.
    View in: PubMed
    Score: 0.174
  9. Hsu JC, Ross-Degnan D, Wagner AK, Cheng CL, Yang YH, Zhang F, Lu CY. Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies. J Pharm Policy Pract. 2015; 8(1):15.
    View in: PubMed
    Score: 0.173
  10. Lu CY, Lupton C, Rakowsky S, Babar ZU, Ross-Degnan D, Wagner AK. Patient access schemes in Asia-pacific markets: current experience and future potential. J Pharm Policy Pract. 2015; 8(1):6.
    View in: PubMed
    Score: 0.171
  11. Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK. Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. J Pharm Policy Pract. 2015; 8(1):7.
    View in: PubMed
    Score: 0.171
  12. Hsu JC, Lu CY, Wagner AK, Chan KA, Lai MS, Ross-Degnan D. Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study. Health Policy. 2014 Jun; 116(2-3):196-205.
    View in: PubMed
    Score: 0.157
  13. Lu CY, Adams AS, Ross-Degnan D, Zhang F, Zhang Y, Salzman C, Soumerai SB. Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatr Serv. 2011 Feb; 62(2):186-93.
    View in: PubMed
    Score: 0.129
  14. Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2011 Jan; 33(1):135-44.
    View in: PubMed
    Score: 0.128
  15. Lu CY, Soumerai SB, Ross-Degnan D, Zhang F, Adams AS. Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Med Care. 2010 Jan; 48(1):4-9.
    View in: PubMed
    Score: 0.120
  16. Lu CY, Ross-Degnan D, Soumerai SB, Pearson SA. Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Serv Res. 2008 Apr 07; 8:75.
    View in: PubMed
    Score: 0.106
  17. Wharam JF, Wallace J, Zhang F, Xu X, Lu CY, Hernandez A, Ross-Degnan D, Newhouse JP. Association Between Switching to a High-Deductible Health Plan and Major Cardiovascular Outcomes. JAMA Netw Open. 2020 Jul 01; 3(7):e208939.
    View in: PubMed
    Score: 0.062
  18. Wharam JF, Lu CY, Zhang F, Callahan M, Xu X, Wallace J, Soumerai S, Ross-Degnan D, Newhouse JP. High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes. Ann Intern Med. 2018 12 18; 169(12):845-854.
    View in: PubMed
    Score: 0.055
  19. Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L, Ross-Degnan D, Wharam JF. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans. Breast Cancer Res Treat. 2018 Sep; 171(2):449-459.
    View in: PubMed
    Score: 0.054
  20. Adams AS, Madden JM, Zhang F, Lu CY, Ross-Degnan D, Lee A, Soumerai SB, Gilden D, Chawla N, Griggs JJ. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer. Value Health. 2017 12; 20(10):1345-1354.
    View in: PubMed
    Score: 0.050
  21. Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF. Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 11; 160(2):385.
    View in: PubMed
    Score: 0.048
  22. Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF. Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):333-40.
    View in: PubMed
    Score: 0.047
  23. Sruamsiri R, Wagner AK, Ross-Degnan D, Lu CY, Dhippayom T, Ngorsuraches S, Chaiyakunapruk N. Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis. BMJ Open. 2016 Mar 17; 6(3):e008671.
    View in: PubMed
    Score: 0.046
  24. Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK. Policies and programs to facilitate access to targeted cancer therapies in Thailand. PLoS One. 2015; 10(3):e0119945.
    View in: PubMed
    Score: 0.043
  25. Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2010 Apr; 32(4):729-41; discussion 716.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.